Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Total Current Liabilities (2016 - 2025)

Westlake Chemical Partners' Total Current Liabilities history spans 13 years, with the latest figure at $51.3 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 7.35% year-over-year to $51.3 million; the TTM value through Dec 2025 reached $51.3 million, down 7.35%, while the annual FY2025 figure was $51.3 million, 7.35% down from the prior year.
  • Total Current Liabilities reached $51.3 million in Q4 2025 per WLKP's latest filing, down from $55.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $454.0 million in Q1 2022 to a low of $42.6 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $86.9 million, with a median of $55.9 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 966.43% in 2022, then tumbled 88.66% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $106.8 million in 2021, then plummeted by 37.32% to $66.9 million in 2022, then dropped by 15.84% to $56.3 million in 2023, then decreased by 1.71% to $55.4 million in 2024, then decreased by 7.35% to $51.3 million in 2025.
  • Per Business Quant, the three most recent readings for WLKP's Total Current Liabilities are $51.3 million (Q4 2025), $55.1 million (Q3 2025), and $72.9 million (Q2 2025).